| About the author: |
Semenyna H.B., Shatylovych K.L., Fartushok T.V., Komissarova O.S., Yurchyshyn O.M. |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
The article presents the results of hormonal parameters and metabolic homeostasis in women with polycystic ovary syndrome (PCOS) and a treatment method developed on this basis. 67 women with PCOS (main group) and 50 healthy women (control group) were under the supervision. The results showed that in women with PCOS hormonal and metabolic disorders are significant, among which a prominent place is occupied by disorders of central regulation of ovarian function, hyperandrogenism, hypoprogesteronemia, insulin resistance on the background of impaired adrenal response to change. Taking into account the pathophysiological multifactority of PCOS and in order to avoid polypharmacy, patients with PCOS were offered a combined drug based on myo-inositol in combination with Lagerstroemia speciosa extract, vitamin D3, methyl folate and chromium. The treatment lasted for 3 months. Clinical evidence of treatment efficacy was spontaneous ovulation (25%) and positive attempts to induce ovulation in resistant patients (40%), probably due to improved ovum quality, hormonal balance, and reduced incidence of insulin resistance. As a result of treatment, 64% (43/67) of patients with PCOS had a menstrual cycle improvement. 33% (22/67) of women reported a reduction in hyperandrogenic dermopathy. No side effects were observed during treatment. |
| Tags |
polycystic ovary syndrome, myo-inositol, treatment |
| Bibliography |
- Semenyna HB. Endokrynni ta obminno-metabolichni porushennya v zhinok iz syndromom polikistoznykh yayechnykiv i novi mozhlyvosti yikhnyoyi korektsiyi. Reproduktyvna endokrynolohiya. 2016; 6(32):69-76.[in Ukrainian]
- Azadi-Yazdi M, Nadjarzaden A, Khosravi-Boroujeni H, Salehi-Abargouei A. The effect of vitamin D supplementation on the androgenic profile in patients with polycystic ovary syndrome: systematic review and meta-analysis of clinical trias. Horm Metab Res. 2017; 49(3):174-179.
- Eichholzer M, Tonz O, Zimmermann R. Folic acid: a public-health challenge. Lancet. 2016; 367:1352-1361.
- Gard D, Tal R. Inositol treatment and ART outcomes in women with PCOS. Int J Endocrinol. 2016; 201:1-9.
- Genazzani AD, Prati A, Santogni S. Differential insulin response to myo-inositol administration in obese polycystic ovarian syndrome patients. Gynecol Endocrinol. 2012; 28:969-973.
- Hayashi T, Maruyama H, Kasai R, Hattori K, Takasuga S, Hazeri O et al. Ellagitannins from Lagerstroemia speciosa as activators of glucose transport in fat cells. Planta Med. 2012; 68(2):173-175.
- Irani M, Seifer DB, Grazi RV, Irani S, Rosenwaks Z, Tal R. Vitamin D decreases serum VEGF correlating with clinical improvement in vitamin D-deficient women with PCOS: a randomized placebo-controlled trial. Nutrients. 2017; 9(4):334.
- Iuorno MJ, Nestler JE. Insulin-lovering drugs in polycystic ovary syndrome. Obstet Gynecol Clin N Am. 2011; 128:453-464.
- Kamenov Z, KovarovG, Gateva A, Carlomagno G, Genazzani AD. Ovulation induction with myo-inositol alone and in combination with clomiphen citrate in polycystic ovarian syndrome patients with insulin resistance. Gynec Endocrin. 2015; 31(2):131-135.
- Miura T, Takagi S, Ishida T. Management of diabetes and its complications with Banaba and corosolic acide. Evid Based Compl Alternat Med. 2012; 3(28):44-49.
- Nestler JE, Jakubowicz DJ. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian p450c17 alfa activity and serum androgens. J Clin Endocrinol Metab. 2017; 82:4075-4079.
- Papaleo E, Unfer V, Baillargeon J.P. Myo-inositol in patients with polycystic ovary syndrome : a novel method for ovulation induction. Gynecol Endocrinol. 2017; 123:700-703.
- Paradisi G, Steinberg HO, Hempfling A. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation. 2011; 103:1410-1415.
- Simi G, Genazzani AR, Obino MR. Inositol and in vitro fertilization with embrio transfer. Int J Endocrinol. 2017; 217:1-5.
- Venturella R. Assesment of the modification of the clinical, endocrinol and metabolical profile of patients with PCOS treated with myo-inositol. Minerva Ginecol. 2010; 64:239-243.
|
| Publication of the article |
«World of Medicine and Biology» №2(72), 2020 year, 125-129 pages, index UDK 618.II-006.2-085 |
| DOI |
10.26724/2079-8334-2020-2-72-125-129 |
